IN VITRO ONCOLOGY & IMMUNO-ONCOLOGY
ASSAY SERVICES
Gain insights into your therapeutic candidates with our in vitro Ready-2-Go assay services, or collaborate with our team to build your customized assay.
ADVANCING DRUG DEVELOPMENT IN
ONCOLOGY & IMMUNO-ONCOLOGY
Oncology and immuno-oncology (I-O) research has dominated the drug-development field for decades, and the building and understanding of predictive, 2D and 3D human models for assaying novel therapeutics’ impacts continue to evolve. Our assay services use cutting-edge, cell-culture techniques to offer biologically relevant systems, so you can avoid the expense of animal models while expanding assay throughput and shortening the time needed to get actionable data.
READY-2-GO ASSAY SERVICES
Choose from a list of predefined, in vitro assay offerings designed to deliver high-quality data, fast.
![]()
R2G CELL HEALTH
Multiplexed readouts of proliferation, viability, and apoptosis.
Learn more
![]()
R2G MITOCHONDRIAL HEALTH
Screen for changes in mitochondrial membrane potential.
Learn more
![]()
R2G LUNG FIBROSIS
Fibrotic induction and inhibition are measured in lung fibroblasts.
Learn more
![]()
R2G LIVER FIBROSIS
Fibrotic induction and inhibition are measured in stellate cells.
Learn more
![]()
R2G AAV GENE DELIVERY
Assess AAV transduction in various cell types.
Learn more
APPLICABLE DISEASES
| Preclinical Toxicity | Oncology | Pulmonary Fibrosis | NASH/Liver Cirrhosis | Neurodegen. (AD, PD, MS) |
Psychiatric Disorders | Neuro-development | |
| R2G Cell Health | ✔ | ✔ | ✔ | ✔ | |||
| R2G Mitochondrial Health | ✔ | ✔ | ✔ | ✔ | |||
| R2G Lung Fibrosis | ✔ | ✔ | |||||
| R2G Liver Fibrosis | ✔ | ✔ | |||||
| R2G AAV Gene Delivery | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ |
BUILD YOUR OWN CUSTOM ASSAY
Can't find what you need? Collaborate with our team to design a custom assay suited to your research needs.
- In vitro models
- Assay Types
- Therapeutic Modalities
Examples of in vitro models we use in mono- or multi-cultures:
- Cell lines (e.g., A549, A-375, HCT116, U-2 OS)
- Patient-derived xenografts (PDX)
- PDX-derived cell lines
- 2D and 3D formats
- Primary tumor material

Examples of assays we deliver:
- Tumor-cell killing
- Dynamics of 2D vs. 3D responses to therapeutics
- Immune cell-tumor interaction
- Influence of tumor microenvironments on therapeutic efficacy and timing
- Off-target effects (e.g., cell painting)
- Cellular uptake or localization of therapeutic agents
- Subcellular dynamics of proteins, organelles, and trafficking

Examples of therapeutic modalities we test:
- Small and large molecules
- Biologics
- AAV
- Lipid nanoparticles (LNP)
- Lentivirus

CONTACT US
Let's discuss how we can help with your research.
